Edition:
United Kingdom

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

1.85USD
19 Oct 2018
Change (% chg)

$-0.07 (-3.65%)
Prev Close
$1.92
Open
$1.94
Day's High
$1.95
Day's Low
$1.84
Volume
8,692
Avg. Vol
17,357
52-wk High
$17.22
52-wk Low
$1.84

Latest Key Developments (Source: Significant Developments)

Regulus Therapeutics Says To Incur Charges Of About $1.5 Mln For Employee Severance & Other Termination Benefits
Friday, 6 Jul 2018 

July 6 (Reuters) - Regulus Therapeutics Inc ::REGULUS THERAPEUTICS - TO INCUR CHARGES OF ABOUT $1.5 MILLION FOR EMPLOYEE SEVERANCE & OTHER TERMINATION BENEFITS REGARDING 60 PERCENT WORKFORCE REDUCTION.REGULUS THERAPEUTICS SAYS SEVERANCE PAYMENTS ARE EXPECTED TO BE PAID IN FULL BY THE END OF Q3 2018 - SEC FILING.  Full Article

Regulus Therapeutics Q3 loss per share $0.18
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Regulus Therapeutics Inc ::Regulus reports third quarter 2017 financial results and recent events.Q3 revenue was less than $100,000.Q3 loss per share $0.18.Q3 revenue view $864,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.  Full Article

Regulus Q3 loss per share $0.18
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Regulus Therapeutics Inc ::Regulus reports third quarter 2017 financial results and recent events.Q3 revenue $100,000.Q3 loss per share $0.18.Q3 revenue view $864,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.  Full Article